Potential modes of intercellular α-synuclein transmission

International Journal of Molecular Sciences

Volumn 18, Issue 2, 2017, Pages

  Valdinocci, Dario ^a   Radford, Rowan A W ^b   Siow, Sue Maye ^a   Chung, Roger S ^b   Pountney, Dean L ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Dementia with Lewy bodies; Exosome; Gliosis; Glymphatic; Multiple system atrophy; Parkinson s disease; Tunneling nanotube; synuclein

Indexed keywords

ALPHA SYNUCLEIN; LYMPHOCYTE ACTIVATING GENE 3; NANOTUBE; PEPTIDES AND PROTEINS; TOLL LIKE RECEPTOR; TRANSMEMBRANE 9 SUPERFAMILY MEMBER 2; UBIQUITIN; UNCLASSIFIED DRUG; PROTEIN BINDING;

CELL TRANSPORT; CYTOTOXICITY; DEMENTIA; DISEASE COURSE; ENDOCYTOSIS; EXOCYTOSIS; EXOSOME; HUMAN; NONHUMAN; PARKINSONISM; PATHOGENESIS; PROTEIN TRANSPORT; REVIEW; SHY DRAGER SYNDROME; ANIMAL; ASTROCYTE; BIOLOGICAL MODEL; CELL COMMUNICATION; DIFFUSE LEWY BODY DISEASE; EXTRACELLULAR SPACE; INTRACELLULAR SPACE; LEWY BODY; METABOLISM; MICROGLIA; PARKINSON DISEASE; PATHOLOGY; PROTEINOSIS;

ALPHA-SYNUCLEIN; ANIMALS; ASTROCYTES; CELL COMMUNICATION; EXOSOMES; EXTRACELLULAR SPACE; HUMANS; INTRACELLULAR SPACE; LEWY BODIES; LEWY BODY DISEASE; MICROGLIA; MODELS, BIOLOGICAL; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN BINDING; PROTEIN TRANSPORT;

EID: 85013637943     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18020469     Document Type: Review

References (143)

1. Barbour, R.; Kling, K.; Anderson, J.; Banducci, K.; Cole, T.; Diep, L.; Fox, M.; Goldstein, J.; Soriano, F.; Seubert, P.; et al. Red Blood Cells Are the Major Source of α-Synuclein in Blood. Neurodegener. Dis. 2008, 5, 55-59.
2. Theillet, F.; Binolfi, A.; Bekei, B.; Martorana, A.; Rose, H.; Stuiver, M.; Verzini, S.; Lorenz, D.; van Rossum, M.; Goldfarb, D.; et al. Structural disorder of monomeric α-synuclein persists in mammalian cells. Nature 2016, 530, 45-50.
3. Weinreb, P.; Zhen, W.; Poon, A.; Conway, K.; Lansbury, P. NACP, A Protein Implicated in Alzheimer’s Disease and Learning, Is Natively Unfolded. Biochemistry 1996, 35, 13709-13715.
4. Cheng, F.; Vivacqua, G.; Yu, S. The role of α-synuclein in neurotransmission and synaptic plasticity. J. Chem. Neuroanat. 2011, 42, 242-248.
5. Burre, J.; Sharma, M.; Tsetsenis, T.; Buchman, V.; Etherton, M.; Sudhof, T. α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro. Science 2010, 329, 1663-1667.
6. Perez, R.; Waymire, J.; Lin, E.; Liu, J.; Guo, F.; Zigmond, M. A role for α-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 2002, 22, 3090-3099.
7. Larsen, K.; Schmitz, Y.; Troyer, M.; Mosharov, E.; Dietrich, P.; Quazi, A.; Savalle, M.; Nemani, V.; Chaudhry, F.; Edwards, R.; et al. α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis. J. Neurosci. 2006, 26, 11915-11922.
8. Yavich, L.; Jäkälä, P.; Tanila, H. Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in α-synuclein knockout and A30P transgenic mice. J. Neurochem. 2006, 99, 724-732.
9. Yavich, L.; Tanilla, H.; Vepsalainen, S.; Jakala, P. Role of α-Synuclein in Presynaptic Dopamine Recruitment. J. Neurosci. 2004, 24, 11165-11170.
10. Bartels, T.; Choi, J.; Selkoe, D. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 2011, 477, 107-110.
11. Jakes, R.; Spillantini, M.; Goedert, M. Identification of two distinct synucleins from human brain. FEBS Lett. 1994, 345, 27-32.
12. Luth, E.; Bartels, T.; Dettmer, U.; Kim, N.; Selkoe, D. Purification of α-Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity. Biochemistry 2015, 54, 279-292.
13. Burré, J.; Vivona, S.; Diao, J.; Sharma, M.; Brunger, A.; Südhof, T. Properties of native brain α-synuclein. Nature 2013, 498, E4-E6.
14. McCann, H.; Stevens, C.; Cartwright, H.; Halliday, G. α-Synucleinopathy phenotypes. Park. Relat. Disord. 2014, 20, S62-S67.
15. Sveinbjornsdottir, S. The clinical symptoms of Parkinson’s disease. J. Neurochem. 2016, 139, 318-324.
16. Menza, M.; Robertson-Hoffman, D.; Bonapace, A. Parkinson’s disease and anxiety: Comorbidity with depression. Biol. Psychiatry 1993, 34, 465-470.
17. McKeith, I.; Mintzer, J.; Aarsland, D.; Burn, D.; Chiu, H.; Cohen-Mansfield, J.; Dickson, D.; Dubois, B.; Duda, J.; Feldman, H.; et al. Dementia with Lewy bodies. Lancet Neurol. 2004, 3, 19-28.
18. Longo, D.; Fanciulli, A.; Wenning, G. Multiple-System Atrophy. N. Engl. J. Med. 2015, 372, 249-263.
19. Ubhi, K.; Low, P.; Masliah, E. Multiple system atrophy: A clinical and neuropathological perspective. Trends Neurosci. 2011, 34, 581-590.
20. Braak, H.; Tredici, K.; Rüb, U.; de Vos, R.; Jansen Steur, E.; Braak, E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 2003, 24, 197-211.
21. Marttila, R.; Rhine, U. Progression and survival in Parkinson’s disease. Acta Neurol. 1991, 136, 24-28.
22. Wenning, G.; Stefanova, N. Recent developments in multiple system atrophy. J. Neurol. 2009, 256, 1791-1808.
23. Williams, M.; Xiong, C.; Morris, J.; Galvin, J. Survival and mortality differences between dementia with Lewy bodies vs. Alzheimer disease. Neurology 2006, 67, 1935-1941.
24. Spillantini, M.; Schmidt, M.; Lee, V.; Trojanowski, J.; Jakes, R.; Goedert, M. α-Synuclein in Lewy bodies. Nature 1997, 388, 839-840.
25. Engelender, S. Ubiquitination of α-synuclein and autophagy in Parkinson’s disease. Autophagy 2008, 4, 372-374.
26. Braak, H.; Sandmann-Keil, D.; Gai, W.; Braak, E. Extensive axonal Lewy neurites in Parkinson’s disease: A novel pathological feature revealed by α-synuclein immunocytochemistry. Neurosci. Lett. 1999, 265, 67-69.
27. Galloway, P.; Mulvihill, P.; Perry, G. Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am. J. Pathol. 1992, 140, 809-822.
28. Kanazawa, T.; Uchihara, T.; Takahashi, A.; Nakamura, A.; Orimo, S.; Mizusawa, H. Three-Layered Structure Shared Between Lewy Bodies and Lewy Neurites—Three-Dimensional Reconstruction of Triple-Labeled Sections. Brain Pathol. 2008, 18, 415-422.
29. Miki, Y.; Mori, F.; Tanji, K.; Wakabayashi, K. Athology of neuro-glial α-synucleinopathy (Lewy body disease and multiple system atrophy). Hirosaki Med. J. 2010, 61, 80-88.
30. Tu, P.; Galvin, J.; Baba, M.; Giasson, B.; Tomita, T.; Leight, S.; Nakajo, S.; Iwatsubo, T.; Trojanowski, J.; Lee, V. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann. Neurol. 1998, 44, 415-422.
31. Grazia Spillantini, M.; Anthony Crowther, R.; Jakes, R.; Cairns, N.; Lantos, P.; Goedert, M. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci. Lett. 1998, 251, 205-208.
32. Ahmed, Z.; Asi, Y.; Sailer, A.; Lees, A.; Houlden, H.; Revesz, T.; Holton, J. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol. Appl. Neurobiol. 2012, 38, 4-24.
33. Asi, Y.; Simpson, J.; Heath, P.; Wharton, S.; Lees, A.; Revesz, T.; Houlden, H.; Holton, J. α-Synuclein mRNA expression in oligodendrocytes in MSA. Glia 2014, 62, 964-970.
34. Djelloul, M.; Holmqvist, S.; Boza-Serrano, A.; Azevedo, C.; Yeung, M.; Goldwurm, S.; Frisén, J.; Deierborg, T.; Roybon, L. α-Synuclein Expression in the Oligodendrocyte Lineage: An In Vitro and In Vivo Study Using Rodent and Human Models. Stem Cell Rep. 2015, 5, 174-184.
35. Lesage, S.; Anheim, M.; Letournel, F.; Bousset, L.; Honoré, A.; Rozas, N.; Pieri, L.; Madiona, K.; Dürr, A.; Melki, R.; et al. G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann. Neurol. 2013, 73, 459-471.
36. Polymeropoulos, M. Mutation in the α-Synuclein Gene Identified in Families with Parkinson’s Disease. Science 1997, 276, 2045-2047.
37. Chartier-Harlin, M.; Kachergus, J.; Roumier, C.; Mouroux, V.; Douay, X.; Lincoln, S.; Levecque, C.; Larvor, L.; Andrieux, J.; Hulihan, M.; et al. α-Synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 2004, 364, 1167-1169.
38. Simón-Sánchez, J.; Schulte, C.; Bras, J.; Sharma, M.; Gibbs, J.; Berg, D.; Paisan-Ruiz, C.; Lichtner, P.; Scholz, S.; Hernandez, D.; et al. Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat. Genet. 2009, 41, 1308-1312.
39. Nalls, M.; Pankratz, N.; Lill, C.; Do, C.; Hernandez, D.; Saad, M.; DeStefano, A.; Kara, E.; Bras, J.; Sharma, M.; et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat. Genet. 2014, 46, 989-993.
40. Satake, W.; Nakabayashi, Y.; Mizuta, I.; Hirota, Y.; Ito, C.; Kubo, M.; Kawaguchi, T.; Tsunoda, T.; Watanabe, M.; Takeda, A.; et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease. Nat. Genet. 2009, 41, 1303-1307.
41. Rcom-H’cheo-Gauthier, A.; Osborne, S.; Meedeniya, A.; Pountney, D. Calcium: α-Synuclein Interactions in α-Synucleinopathies. Front. Neurosci. 2016, 10, 570.
42. Fujiwara, H.; Hasegawa, M.; Dohmae, N.; Kawashima, A.; Masliah, E.; Goldberg, M.; Shen, J.; Takio, K.; Iwatsubo, T. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 2002, 4, 160-164.
43. Reynolds, A.; Glanzer, J.; Kadiu, I.; Ricardo-Dukelow, M.; Chaudhuri, A.; Ciborowski, P.; Cerny, R.; Gelman, B.; Thomas, M.; Mosley, R.; et al. Nitrated α-synuclein-activated microglial profiling for Parkinson’s disease. J. Neurochem. 2007, 104, 1504-1525.
44. Cookson, M. α-Synuclein and neuronal cell death. Mol. Neurodegener. 2009, 4, 9.
45. Anderson, J.; Walker, D.; Goldstein, J.; de Laat, R.; Banducci, K.; Caccavello, R.; Barbour, R.; Huang, J.; Kling, K.; Lee, M.; et al. Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease. J. Biol. Chem. 2006, 281, 29739-29752.
46. Ueda, K.; Fukushima, H.; Masliah, E.; Xia, Y.; Iwai, A.; Yoshimoto, M.; Otero, D.; Kondo, J.; Ihara, Y.; Saitoh, T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 1993, 90, 11282-11286.
47. Bousset, L.; Pieri, L.; Ruiz-Arlandis, G.; Gath, J.; Jensen, P.; Habenstein, B.; Madiona, K.; Olieric, V.; Böckmann, A.; Meier, B.; et al. Structural and functional characterization of two α-synuclein strains. Nat. Commun. 2013, 4, 2575.
48. Gai, W.; Pountney, D.; Power, J.; Li, Q.; Culvenor, J.; McLean, C.; Jensen, P.; Blumbergs, P. α-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp. Neurol. 2003, 181, 68-78.
49. Pountney, D.; Lowe, R.; Quilty, M.; Vickers, J.; Voelcker, N.; Gai, W. Annular α-synuclein species from purified multiple system atrophy inclusions. J. Neurochem. 2004, 90, 502-512.
50. Paviour, D.; Price, S.; Lees, A.; Fox, N. MRI derived brain atrophy in PSP and MSA-P. J. Neurol. 2007, 254, 478-481.
51. Brettschneider, J.; Irwin, D.; Boluda, S.; Byrne, M.; Fang, L.; Lee, E.; Robinson, J.; Suh, E.; van Deerlin, V.; Toledo, J.; et al. Progression of α-synuclein pathology in multiple system atrophy of the cerebellar type. Neuropathol. Appl. Neurobiol. 2016.
52. McKeith, I.; Dickson, D.; Lowe, J.; Emre, M.; O’Brien, J.; Feldman, H.; Cummings, J.; Duda, J.; Lippa, C.; Perry, E.; et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology 2005, 65, 1863-1872.
53. Peelaerts, W.; Bousset, L.; van der Perren, A.; Moskalyuk, A.; Pulizzi, R.; Giugliano, M.; van den Haute, C.; Melki, R.; Baekelandt, V. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 2015, 522, 340-344.
54. Luk, K.; Kehm, V.; Carroll, J.; Zhang, B.; O’Brien, P.; Trojanowski, J.; Lee, V. Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice. Science 2012, 338, 949-953.
55. Osterberg, V.; Spinelli, K.; Weston, L.; Luk, K.; Woltjer, R.; Unni, V. Progressive Aggregation of α-Synuclein and Selective Degeneration of Lewy Inclusion-Bearing Neurons in a Mouse Model of Parkinsonism. Cell Rep. 2015, 10, 1252-1260.
56. Paumier, K.; Luk, K.; Manfredsson, F.; Kanaan, N.; Lipton, J.; Collier, T.; Steece-Collier, K.; Kemp, C.; Celano, S.; Schulz, E.; et al. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol. Dis. 2015, 82, 185-199.
57. Sacino, A.; Brooks, M.; McGarvey, N.; McKinney, A.; Thomas, M.; Levites, Y.; Ran, Y.; Golde, T.; Giasson, B. Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein. Acta Neuropathol. Commun. 2013, 1, 38.
58. Rey, N.L.; Steiner, J.A.; Maroof, N.; Luk, K.C.; Madaj, Z.; Trojanowski, J.Q.; Lee, V.M.; Brundin, P. Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease. J. Exp. Med. 2016, 213, 1759-1778.
59. Kovacs, G.; Budka, H. Prion Diseases: From Protein to Cell Pathology. Am. J. Pathol. 2008, 172, 555-565.
60. Goedert, M. Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein. Science 2015, 349.
61. Iwai, A. Properties of NACP/α-synuclein and its role in Alzheimer’s disease. Biochim. Biophys. Acta Mol. Basis Dis. 2000, 1502, 95-109.
62. Rodriguez, J.; Ivanova, M.; Sawaya, M.; Cascio, D.; Reyes, F.; Shi, D.; Sangwan, S.; Guenther, E.; Johnson, L.; Zhang, M.; et al. Structure of the toxic core of α-synuclein from invisible crystals. Nature 2015, 525, 486-490.
63. Radford, R.; RcomH’cheo-Gauthier, A.; Wong, M.B.; Eaton, E.D.; Quilty, M.; Blizzard, C.; Norazit, A.; Meedeniya, A.; Vickers, J.C.; Gai, W.P.; et al. The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to α-synuclein inclusions. Mol. Cell Neurosci. 2015, 65, 68-81.
64. Recasens, A.; Dehay, B.; Bové, J.; Carballo-Carbajal, I.; Dovero, S.; Pérez-Villalba, A.; Fernagut, P.; Blesa, J.; Parent, A.; Perier, C.; et al. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann. Neurol. 2014, 75, 351-362.
65. Prusiner, S.; Woerman, A.; Mordes, D.; Watts, J.; Rampersaud, R.; Berry, D.; Patel, S.; Oehler, A.; Lowe, J.; Kravitz, S.; et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl. Acad. Sci. USA 2015, 112, E5308-E5317.
66. Cykowski, M.; Coon, E.; Powell, S.; Jenkins, S.; Benarroch, E.; Low, P.; Schmeichel, A.; Parisi, J. Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 2015, 138, 2293-2309.
67. Li, J.; Englund, E.; Holton, J.; Soulet, D.; Hagell, P.; Lees, A.; Lashley, T.; Quinn, N.; Rehncrona, S.; Björklund, A.; et al. Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation. Nat. Med. 2008, 14, 501-503.
68. Kordower, J.; Chu, Y.; Hauser, R.; Freeman, T.; Olanow, C. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat. Med. 2008, 14, 504-506.
69. Ahn, T.; Langston, J.; Aachi, V.; Dickson, D. Relationship of neighboring tissue and gliosis to α-synuclein pathology in a fetal transplant for Parkinson’s disease. Am. J. Neurodegener. Dis. 2012, 1, 49-59.
70. El-Agnaf, O.; Salem, S.; Paleologou, K.; Curran, M.; Gibson, M.; Court, J.; Schlossmacher, M.; Allsop, D. Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease. FASEB J. 2006, 20, 419-425.
71. Danzer, K.; Ruf, W.; Putcha, P.; Joyner, D.; Hashimoto, T.; Glabe, C.; Hyman, B.; McLean, P. Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 2011, 25, 326-336.
72. Fontaine, S.; Zheng, D.; Sabbagh, J.; Martin, M.; Chaput, D.; Darling, A.; Trotter, J.; Stothert, A.; Nordhues, B.; Lussier, A.; et al. DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative-associated proteins. EMBO J. 2016, 35, 1537-1549.
73. Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.; Lötvall, J. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654-659.
74. Gibbings, D.; Ciaudo, C.; Erhardt, M.; Voinnet, O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 2009, 11, 1143-1149.
75. Lancaster, G.; Febbraio, M. Exosome-dependent Trafficking of HSP70: A novel secretory pathway for cellular stress proteins. J. Biol. Chem. 2005, 280, 23349-23355.
76. Beaudoin, A.; Grondin, G. Shedding of vesicular material from the cell surface of eukaryotic cells: Different cellular phenomena. Biochim. Biophys. Acta Rev. Biomembr. 1991, 1071, 203-219.
77. Denzer, K.; Kleijmeer, M.; Heijnen, H.; Stoorvogel, W.; Geuze, H. Exosome: From internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 2000, 113, 3365-3374.
78. Fitzner, D.; Schnaars, M.; van Rossum, D.; Krishnamoorthy, G.; Dibaj, P.; Bakhti, M.; Regen, T.; Hanisch, U.; Simons, M. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci. 2011, 124, 447-458.
79. Frühbeis, C.; Fröhlich, D.; Kuo, W.; Krämer-Albers, E. Extracellular vesicles as mediators of neuron-glia communication. Front. Cell. Neurosci. 2013, 7, 182.
80. Frühbeis, C.; Fröhlich, D.; Kuo, W.; Amphornrat, J.; Thilemann, S.; Saab, A.; Kirchhoff, F.; Möbius, W.; Goebbels, S.; Nave, K.; et al. Neurotransmitter-Triggered Transfer of Exosomes Mediates Oligodendrocyte-Neuron Communication. PLoS Biol. 2013, 11, e1001604.
81. Davis, C.; Kim, K.; Bushong, E.; Mills, E.; Boassa, D.; Shih, T.; Kinebuchi, M.; Phan, S.; Zhou, Y.; Bihlmeyer, N.; et al. Transcellular degradation of axonal mitochondria. Proc. Natl. Acad. Sci. USA 2014, 111, 9633-9638.
82. Hayakawa, K.; Esposito, E.; Wang, X.; Terasaki, Y.; Liu, Y.; Xing, C.; Ji, X.; Lo, E. Transfer of mitochondria from astrocytes to neurons after stroke. Nature 2016, 535, 551-555.
83. Von Bartheld, C.; Altick, A. Multivesicular bodies in neurons: Distribution, protein content, and trafficking functions. Prog. Neurobiol. 2011, 93, 313-340.
84. Danzer, K.; Kranich, L.; Ruf, W.; Cagsal-Getkin, O.; Winslow, A.; Zhu, L.; Vanderburg, C.; McLean, P. Exosomal cell-to-cell transmission of α synuclein oligomers. Mol. Neurodegener. 2012, 7, 42.
85. Alvarez-Erviti, L.; Seow, Y.; Schapira, A.; Gardiner, C.; Sargent, I.; Wood, M.; Cooper, J. Lysosomal dysfunction increases exosome-mediated α-synuclein release and transmission. Neurobiol. Dis. 2011, 42, 360-367.
86. Emmanouilidou, E.; Melachroinou, K.; Roumeliotis, T.; Garbis, S.; Ntzouni, M.; Margaritis, L.; Stefanis, L.; Vekrellis, K. Cell-Produced-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival. J. Neurosci. 2010, 30, 6838-6851.
87. Frohlich, D.; Kuo, W.; Fruhbeis, C.; Sun, J.; Zehendner, C.; Luhmann, H.; Pinto, S.; Toedling, J.; Trotter, J.; Kramer-Albers, E. Multifaceted effects of oligodendroglial exosomes on neurons: Impact on neuronal firing rate, signal transduction and gene regulation. Philos. Trans. R. Soc. B Biol. Sci. 2014, 369.
88. Nakamura, K.; Mori, F.; Kon, T.; Tanji, K.; Miki, Y.; Tomiyama, M.; Kurotaki, H.; Toyoshima, Y.; Kakita, A.; Takahashi, H.; et al. Accumulation of phosphorylated α-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration. Neuropathology 2016, 36, 157-167.
89. Braak, H.; Sastre, M.; Del Tredici, K. Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease. Acta Neuropathol. 2007, 114, 231-241.
90. Piao, Y.; Mori, F.; Hayashi, S.; Tanji, K.; Yoshimoto, M.; Kakita, A.; Wakabayashi, K.; Takahashi, H. α-Synuclein pathology affecting Bergmann glia of the cerebellum in patients with α-synucleinopathies. Acta Neuropathol. 2003, 105, 403-409. [PubMed]
91. Reyes, J.; Rey, N.; Bousset, L.; Melki, R.; Brundin, P.; Angot, E. α-Synuclein transfers from neurons to oligodendrocytes. Glia 2013, 62, 387-398.
92. Desplats, P.; Lee, H.; Bae, E.; Patrick, C.; Rockenstein, E.; Crews, L.; Spencer, B.; Masliah, E.; Lee, S. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc. Natl. Acad. Sci. USA 2009, 106, 13010-13015.
93. Liu, J.; Zhou, Y.; Wang, Y.; Fong, H.; Murray, T.; Zhang, J. Identification of Proteins Involved in Microglial Endocytosis of α-Synuclein. J. Proteome Res. 2007, 6, 3614-3627.
94. Lee, H.; Suk, J.; Bae, E.; Lee, J.; Paik, S.; Lee, S. Assembly-dependent endocytosis and clearance of extracellular α-synuclein. Int. J. Biochem. Cell Biol. 2008, 40, 1835-1849.
95. Konno, M.; Hasegawa, T.; Baba, T.; Miura, E.; Sugeno, N.; Kikuchi, A.; Fiesel, F.; Sasaki, T.; Aoki, M.; Itoyama, Y.; et al. Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: A potent therapeutic target for synucleinopathy. Mol. Neurodegener. 2012, 7, 38.
96. Mao, X.; Ou, M.; Karuppagounder, S.; Kam, T.; Yin, X.; Xiong, Y.; Ge, P.; Umanah, G.; Brahmachari, S.; Shin, J.; et al. Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science 2016, 353.
97. Schimmöller, F.; Dıaz, E.; Mühlbauer, B.; Pfeffer, S. Characterization of a 76kDa endosomal, multispanning membrane protein that is highly conserved throughout evolution. Gene 1998, 216, 311-318.
98. Wadman, M. Rogue protein’s partners offer hope in Parkinson’s disease. Science 2016, 354, 956.
99. Usenovic, M.; Tresse, E.; Mazzulli, J.; Taylor, J.; Krainc, D. Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, α-Synuclein Accumulation, and Neurotoxicity. J. Neurosci. 2012, 32, 4240-4246.
100. Siebert, M.; Sidransky, E.; Westbroek, W. Glucocerebrosidase is shaking up the synucleinopathies. Brain 2014, 137, 1304-1322.
101. Holmes, B.; DeVos, S.; Kfoury, N.; Li, M.; Jacks, R.; Yanamandra, K.; Ouidja, M.; Brodsky, F.; Marasa, J.; Bagchi, D.; et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc. Natl. Acad. Sci. USA 2013, 110, E3138-E3147.
102. Abounit, S.; Bousset, L.; Loria, F.; Zhu, S.; de Chaumont, F.; Pieri, L.; Olivo-Marin, J.; Melki, R.; Zurzolo, C. Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes. EMBO J. 2016, 35, 2120-2138.
103. Agnati, L.; Fuxe, K. Extracellular-vesicle type of volume transmission and tunnelling-nanotube type of wiring transmission add a new dimension to brain neuro-glial networks. Philos. Trans. R. Soc. B Biol. Sci. 2014, 369.
104. Gousset, K.; Schiff, E.; Langevin, C.; Marijanovic, Z.; Caputo, A.; Browman, D.; Chenouard, N.; de Chaumont, F.; Martino, A.; Enninga, J.; et al. Prions hijack tunnelling nanotubes for intercellular spread. Nat. Cell Biol. 2009, 11, 328-336.
105. Eugenin, E.; Gaskill, P.; Berman, J. Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: A potential mechanism for intercellular HIV trafficking. Cell. Immunol. 2009, 254, 142-148.
106. Onfelt, B.; Nedvetzki, S.; Yanagi, K.; Davis, D. Cutting Edge: Membrane Nanotubes Connect Immune Cells. J. Immunol. 2004, 173, 1511-1513.
107. Onfelt, B.; Nedvetzki, S.; Benninger, R.; Purbhoo, M.; Sowinski, S.; Hume, A.; Seabra, M.; Neil, M.; French, P.; Davis, D. Structurally Distinct Membrane Nanotubes between Human Macrophages Support Long-Distance Vesicular Traffic or Surfing of Bacteria. J. Immunol. 2006, 177, 8476-8483.
108. Zhu, D.; Tan, K.; Zhang, X.; Sun, A.; Sun, G.; Lee, J. Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J. Cell Sci. 2005, 118, 3695-3703.
109. Rustom, A.; Saffrich, R.; Markovic, I.; Walther, P.; Gerdes, H. Nanotubular Highways for Intercellular Organelle Transport. Science 2004, 303, 1007-1010.
110. Sun, X.; Wang, Y.; Zhang, J.; Tu, J.; Wang, X.; Su, X.; Wang, L.; Zhang, Y. Tunneling-nanotube direction determination in neurons and astrocytes. Cell Death Dis. 2012, 3, e438.
111. McCoy-Simandle, K.; Hanna, S.; Cox, D. Exosomes and nanotubes: Control of immune cell communication. Int. J. Biochem. Cell Biol. 2016, 71, 44-54.
112. Kettenmann, H.; Hanisch, U.; Noda, M.; Verkhratsky, A. Physiology of Microglia. Physiol. Rev. 2011, 91, 461-553.
113. Jonas, R.; Yuan, T.; Liang, Y.; Jonas, J.; Tay, D.; Ellis-Behnke, R. The Spider Effect: Morphological and Orienting Classification of Microglia in Response to Stimuli in Vivo. PLoS ONE 2012, 7, e30763.
114. Perry, V.; Cunningham, C.; Holmes, C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 2007, 7, 161-167.
115. Neumann, H.; Kotter, M.; Franklin, R. Debris clearance by microglia: An essential link between degeneration and regeneration. Brain 2008, 132, 288-295.
116. Fellner, L.; Stefanova, N. The Role of Glia in α-Synucleinopathies. Mol. Neurobiol. 2012, 47, 575-586.
117. Politis, M.; Su, P.; Piccini, P. Imaging of microglia in patients with neurodegenerative disorders. Front. Pharmacol. 2012, 3.
118. Kaufman, E.; Hall, S.; Surova, Y.; Widner, H.; Hansson, O.; Lindqvist, D. Proinflammatory Cytokines Are Elevated in Serum of Patients with Multiple System Atrophy. PLoS ONE 2013, 8, e62354.
119. Koga, S.; Aoki, N.; Uitti, R.; van Gerpen, J.; Cheshire, W.; Josephs, K.; Wszolek, Z.; Langston, J.; Dickson, D. When DLB, PD, and PSP masquerade as MSA. Neurology 2015, 85, 404-412.
120. Nagatsu, T.; Sawada, M. Inflammatory Process in Parkinsons Disease: Role for Cytokines. Curr. Pharm. Des. 2005, 11, 999-1016.
121. Tufekci, K.; Meuwissen, R.; Genc, S.; Genc, K. Inflammation in Parkinson’s Disease. Adv. Protein Chem. Struct. Biol. 2012, 88, 69-132.
122. Higuchi, M.; Tashiro, M.; Arai, H.; Okamura, N.; Hara, S.; Higuchi, S.; Itoh, M.; Shin, R.; Trojanowski, J.; Sasaki, H. Glucose Hypometabolism and Neuropathological Correlates in Brains of Dementia with Lewy Bodies. Exp. Neurol. 2000, 162, 247-256.
123. Chu, Y.; Dodiya, H.; Aebischer, P.; Olanow, C.; Kordower, J. Alterations in lysosomal and proteasomal markers in Parkinson’s disease: Relationship to α-synuclein inclusions. Neurobiol. Dis. 2009, 35, 385-398.
124. Masliah, E.; Rockenstein, E.; Adame, A.; Alford, M.; Crews, L.; Hashimoto, M.; Seubert, P.; Lee, M.; Goldstein, J.; Chilicote, T.; et al. Effects of α-synuclein immunization in a mouse model of Parkinson’s disease. Neuron 2005, 46, 857-868.
125. Park, J.; Kim, K.; Lee, S.; Ryu, J.; Chung, K.; Choo, Y.; Jou, I.; Kim, J.; Park, S. On the mechanism of internalization of α-synuclein into microglia: Roles of ganglioside GM1 and lipid raft. J. Neurochem. 2009, 110, 400-411.
126. Fortin, D.; Troyer, M.; Nakamura, K.; Kubo, S.; Anthony, M.; Edwards, R. Lipid Rafts Mediate the Synaptic Localization of α-Synuclein. J. Neurosci. 2004, 24, 6715-6723.
127. Bar-On, P.; Crews, L.; Koob, A.; Mizuno, H.; Adame, A.; Spencer, B.; Masliah, E. Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease. J. Neurochem. 2008, 105, 1656-1667.
128. Kubo, S.; Nemani, V.; Chalkley, R.; Anthony, M.; Hattori, N.; Mizuno, Y.; Edwards, R.; Fortin, D. A Combinatorial Code for the Interaction of α-Synuclein with Membranes. J. Biol. Chem. 2005, 280, 31664-31672.
129. 2 -dependent Lyn phosphorylation. Proc. Natl. Acad. Sci. USA 2015, 112, E1926-E1935.
130. Su, X.; Maguire-Zeiss, K.; Giuliano, R.; Prifti, L.; Venkatesh, K.; Federoff, H. Synuclein activates microglia in a model of Parkinson’s disease. Neurobiol. Aging 2008, 29, 1690-1701.
131. Stefanova, N.; Fellner, L.; Reindl, M.; Masliah, E.; Poewe, W.; Wenning, G. Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons. Am. J. Pathol. 2011, 179, 954-963.
132. Kim, C.; Ho, D.; Suk, J.; You, S.; Michael, S.; Kang, J.; Joong Lee, S.; Masliah, E.; Hwang, D.; Lee, H.; et al. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat. Commun. 2013, 4, 1562.
133. Roodveldt, C.; Labrador-Garrido, A.; Gonzalez-Rey, E.; Lachaud, C.; Guilliams, T.; Fernandez-Montesinos, R.; Benitez-Rondan, A.; Robledo, G.; Hmadcha, A.; Delgado, M.; et al. Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation. PLoS ONE 2013, 8, e79160.
134. Fellner, L.; Irschick, R.; Schanda, K.; Reindl, M.; Klimaschewski, L.; Poewe, W.; Wenning, G.; Stefanova, N. Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia. Glia 2013, 61, 349-360.
135. Tang, Y.; Le, W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol. Neurobiol. 2015, 53, 1181-1194.
136. Asai, H.; Ikezu, S.; Tsunoda, S.; Medalla, M.; Luebke, J.; Haydar, T.; Wolozin, B.; Butovsky, O.; Kügler, S.; Ikezu, T. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 2015, 18, 1584-1593.
137. Vieira, B.D.; Radford, R.A.; Chung, R.S.; Guillemin, G.J.; Pountney, D.L. Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation. Front. Cell Neurosci. 2015, 9, 437.
138. Jessen, N.; Munk, A.; Lundgaard, I.; Nedergaard, M. The Glymphatic System: A Beginner’s Guide. Neurochem. Res. 2015, 40, 2583-2599.
139. Iliff, J.; Wang, M.; Liao, Y.; Plogg, B.; Peng, W.; Gundersen, G.; Benveniste, H.; Vates, G.; Deane, R.; Goldman, S.; et al. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β. Sci. Transl. Med. 2012, 4.
140. Iliff, J.; Chen, M.; Plog, B.; Zeppenfeld, D.; Soltero, M.; Yang, L.; Singh, I.; Deane, R.; Nedergaard, M. Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury. J. Neurosci. 2014, 34, 16180-16193.
141. Hoshi, A.; Tsunoda, A.; Tada, M.; Nishizawa, M.; Ugawa, Y.; Kakita, A. Expression of aquaporin 1 and aquaporin 4 in the temporal neocortex of patients with Parkinson’s disease. Brain Pathol. 2016.
142. Gao, L.; Tang, H.; Nie, K.; Wang, L.; Zhao, J.; Gan, R.; Huang, J.; Zhu, R.; Feng, S.; Duan, Z.; et al. Cerebrospinal fluid α-synuclein as a biomarker for Parkinson’s disease diagnosis: A systematic review and meta-analysis. Int. J. Neurosci. 2014, 125, 645-654.
143. Lundgaard, I.; Lu, M.; Yang, E.; Peng, W.; Mestre, H.; Hitomi, E.; Deane, R.; Nedergaard, M. Glymphatic clearance controls state-dependent changes in brain lactate concentration. J. Cereb. Blood Flow Metab. 2016.